• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Rabbit polyclonal to TPT1.

SMAD2 is a known person in the transforming development aspect β

September 11, 2017 by Katherine Lewis Leave a Comment

SMAD2 is a known person in the transforming development aspect β and activin-signaling pathway. After getting phosphorylated by type I receptors pathway-restricted SMADs associate with SMAD4 (10) translocate towards the nucleus and activate together with many specific transcription elements their respective focus on genes (4 11 The SMAD2 proteins includes three domains (4) the Mad … [Read more…]

Posted in: Blogging Tagged: Rabbit polyclonal to TPT1., Ritonavir

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by